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Cultured mesangial cells from autoimmune MRL-lpr mice have de-
creased secreted and surface M-CSF. M-CSF has been implicated in the
pathogenesis of lupus nephritis in MRL-lpr mice. We recently reported
persistently high levels of serum M-CSF in MRL-lpr mice as early as
one week of age, not present in normal mice including C3H mice. In
addition, M-CSF transcripts in MRL-lpr renal cortex increased with an
increase in the severity of nephritis. Because glomerular mesangial cells
(MC) secrete M-CSF, we investigated whether cultured MRL-lpr MC
secrete more M-CSF than C3H MC. Paradoxically, unstimulated MRL-
lpr MC secreted substantially less M-CSF than C3H MC [26 11 vs.
109 7 colony forming units (CFU)]. We then explored whether MC
could express membrane bound M-CSF. We detected a 31 kDa form of
membrane M-CSF on both MRL-lpr and C3H MC. Fewer MRL-lpr MC
than C3H MC (24 5% vs. 78 5%) expressed membrane M-CSF.
Furthermore, the increase in the mean channel log fluorescence inten-
sity on MRL-lpr MC was considerably less than in C3H MC, indicating
a lower density of M-CSF on MRL-/pr MC. Because our prior studies
established that MRL-!pr kidneys have enhanced expression of TNFa,
we stimulated cultured MC with TNFa. TNFa increased M-CSF
secretion by stimulated MRL-lpr by twofold over unstimulated MRL-
lpr MC, but did not increase M-CSF in C3H MC. In addition, M-CSF
secretion was modestly greater in stimulated MRL-lpr MC compared to
stimulated C3H MC. In conclusion, this is the first report of membrane
M-CSF detectable on cultured MC. These studies note that despite
higher circulating M-CSF and renal M-CSF transcripts in MRL-lpr
mice, cultured MRL-lpr MC have lower basal secreted and membrane
bound M-CSF than cultured C3H MC. TNFa increases secretion of
M-CSF by MRL-lpr MC, but does not enhance membrance M-CSF.
Since these studies are restricted to a comparison of MC from autoim-
mune and normal mice in vitro, we are engaged in further studies to
evaluate in vivo production of M-CSF by MC and the importance of this
growth factor in renal injury.
M-CSF (macrophage-colony stimulating factor) is a hemato-
poietic cytokine that is a chemoattractant for macrophages [1]
as well as a growth and differentiation factor [2] for macro-
phages. MRL-lpr mice are a model of systemic lupus erythe-
matosus (SLE) and develop an aggressive lupus nephritis.
Progressive kidney disease is associated with mesangial cell
proliferation and accumulation of macrophages in the renal
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glomerulus and increased levels of mRNA for the pro-inflam-
matory cytokines TNFa and IL-lp in the renal cortex [3, 4].
Recently, we reported that MRL-lpr mice have an increased
level of circulating M-CSF [colony stimulating factor-i (CSF-
1)1, which may augment macrophage mediated renal injury [5].
M-CSF was detectable in MRL-/pr mice as early as one week of
age, decreased between two to four months of age, and then
increased to the highest levels beginning at four months of age.
Circulating M-CSF was not detected in sera from congenic
MRL-+ +, normal C3H/FeJ (C3H), or two other mouse strains
with the lpr gene. Consistent with serum data, M-CSF tran-
scripts were elevated in the kidneys of MRL-lpr mice, but not
normal C3H/FeJ or congenic MRL-+ + mice with normal renal
function [5]. These results suggest that local production of
M-CSF as well as systemically increased levels may be impor-
tant for the pathogenesis of lupus nephritis.
The factors which regulate M-CSF production within lupus
kidneys are not clear, as mesangial cells from normal and
autoimmune mice express this cytokine [6, 7]. Using a semi-
solid agar colony stimulating assay, we examined whether
M-CSF production capacity differed between mouse strains.
Since several cytokines, including IL-i and TNF, are mem-
brane bound [8—10], we also investigated whether mesangial
cells (MC) from normal and autoimmune strains have a surface
form of M-CSF. Paradoxically, although MRL-lpr have circu-
lating levels of M-CSF not detected in normal mice, unstimu-
lated MRL-lpr MC secreted less M-CSF than normal C3H MC.
However, MRL-lpr MC were readily induced by TNF to
increase M-CSF production, while C3H MC were unresponsive
to this stimulus. Antibody neutralization assays indicated that
secreted colony stimulating factor was exclusively M-CSF and
not GM-CSF. We now report the presence of membrane
M-CSF on MC. Again, contrary to our expectations, the
percentage of unstimulated MRL-lpr MC expressing M-CSF
was much less than the percentage of unstimulated C3H MC
expressing M-CSF as analyzed by flow cytometry. However,
surface expression of M-CSF was not increased with TNFa
stimulation in either MRL-lpr or C3H MC. Western blot anal-
ysis of cell lysates revealed the existence of a 31 kDa form of
M-CSF on MC. We hypothesize that membrane and secreted
M-CSF act to recruit and stimulate macrophages to proliferate
in the glomerulus. In turn, the accumulation of macrophages in
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the glomerulus can generate molecules known to promote renal
injury.
Methods
Mice
Normal C3H/FeJ (H2k) (C3H) and C3H/HeN (H2k), autoim-
mune MRL/MpJ-lpr/lpr (MRL-lpr) (H2k), and MRL/MpJ-+ +
(MRL-+ +) (H2k) female mice were obtained from The Jack-
son Laboratory (Bar Harbor, Maine, USA). All animals were
maintained in our animal facility on standard laboratory chow.
Reagents
Tissue culture media and reagents were from Grand Island
Biological Company (New York. USA). Chemicals were pur-
chased from Sigma (St. Louis, Missouri, USA) unless other-
wise indicated. Polyclonal rabbit anti-mouse L cell-derived
M-CSF (anti-M-CSF antibody) was provided by Dr. R. Shad-
duck, Montefiore Hospital, Pittsburgh, Pennsylvania, USA.
'251-iodinated goat anti-rabbit polyclonal antibody was a gift
from Dr. S. Greenberg, Harvard Medical School (Boston,
Massachusetts, USA). Normal rabbit serum was purchased
from Calbiochem (Behring Diagnostics, La Jolla, California,
USA). Murine rTNFa (0.98 mg/mI, 1.2 x io jslmg was pro-
vided by Genentech (South San Francisco, California, USA).
Mouse L929 cells were obtained from American Type Culture
Center (Rockville, Maryland, USA). Mouse CH33 cells (B cell
tumor cells derived from Bl0.A mice) were a gift from Dr. D.
Perkins, Harvard Medical School (Boston, Massachusetts,
USA).
Mesangial cell isolation and growth
Untransformed MC lines were established and characterized
as previously described [11, 12] using collagenase dispersion of
sieved glomeruli from C3H/FeJ, MRL-lpr or MRL-++ mice
that were between two to four months of age. Cell monolayers
were treated with trypsin (0.025%) EDTA (0.5 mM) and pas-
saged as needed in high (15 to 20%) fetal calf serum (FCS)
containing media.
Colony stimulating assays
M-CSF was assessed as previously described [5]. Bone
marrow cells were obtained from the tibias of 20 g male
C3H/HeN or C3H/FeJ mice and cultured in duplicate in soft
agar [131. Briefly, 1 x io bone marrow cells were added to 30
d test serum or 200 pJ supernatant (SN) and plated in 1 ml 0.3%
Noble agar (Difco, Detroit, Michigan, USA) in McCoy's SA
medium (Gibco) supplemented with 15% fetal calf serum (FCS;
Hyclone, Logan, Utah, USA), 50 M 2-mercaptoethanol (Sig-
ma), 10 U/mI penicillin and 10 g/m1 streptomycin (Gibco) in 35
mm tissue culture plates (Costar, Cambridge, Massachusetts,
USA). Cultures were incubated at 37°C in a humidified 7% CO1
atmosphere and the colonies counted on day 10 to 12 with a
dissecting microscope. Colonies at this time point are macro-
phage colonies as granulocytic colonies do not persist this late
in culture [14]. Results of colony-stimulating activity (CSA) are
reported as colony forming units (CFU)/l05 bone marrow cells.
This assay has a limit of detection of 50 units of M-CSF based
on determination of CFU using murine r-M-CSF. For inhibition
studies, 30 d of test sera or 200 d of culture supernatant was
preincubated with 0.1 to 0.2 ml of various dilutions of either
polyclonal rabbit anti-mouse L cell-derived M-CSF or normal
rabbit serum for 30 minutes at room temperature before assay.
The specificity of M-CSF in sera and supernatant was tested by
preincubation with M-CSF-containing L cell supernatant,
recombinant murine granulocyte macrophage CSF (rGM-CSF)
(Genzyme, Cambridge, Massachusetts, USA) and murine
recombinant interleukin-3 (rIL-3) (Biogen, Cambridge, Massa-
chusetts, USA), as previously described [5].
Flow cytometric analysis
Monolayers of MC were gently trypsinized to produce a
single-cell suspension and labeled using the specific polyclonal
rabbit anti-M-CSF at optimum concentrations. Controls in-
cluded cells without primary antibody or stained with irrelevant
normal rabbit serum at an equivalent dilution to the anti-M-CSF
antibody. Fluorescein (FITC)-conjugated affinity-purified goat
anti-rabbit IgG F(ab')2 was used as a secondary reagent. Cells
were fixed in 2% paraformaldehyde and analyzed on an Epics
flow cytometer (Coulter Electronics, Hialeah, Florida, USA).
Immunoprecipitation and Western blot for surface M-CSF
Confluent cell monolayers were trypsinized, washed three
times in HBSS and then lysed in 1 ml of extract buffer
containing 1% Nonidet P-40 (NP-40), 50 mri KCI, 10 mM NaCI,
1 mM EDTA, 50 mM KH2PO4 buffer (pH 7.5), 2 m phenyl-
methylsulfonyl fluoride (PMSF), and 2 pgJml of antipain, leu-
peptin and pepstatin A. Debris was removed by centnfugation
at 15,000 rpm for 20 minutes and then an aliquot of the lysate
was precleared with normal rabbit serum and Protein-A Seph-
arose for 16 hours. Half of the precleared lysate was immuno-
precipitated by incubation with a 1/100 dilution of anti-M-CSF
antisera for 2 hours, followed by precipitation with Protein-A
Sepharose beads for one hour. The immunoprecipitate was
washed three times with lysis buffer and then twice with PBS
pH 7.2. Buffer containing SDS without reducing agents was
added to the samples, and after boiling for two minutes, 10 d of
either cell lysate extracts, pre-cleared lysates, immunoprecipi-
tated lysates or culture supernatant was electrophoresed
through a 10 to 20% SDS polyacrylamide gradient gel or a 12%
stacking gel, depending on the particular experiment [151. The
proteins were transferred to nitrocellulose using standard tech-
niques under reducing conditions. Blots were incubated with
rabbit anti-M-CSF antisera (1:500), followed by goat anti-rabbit
alkaline phosphatase (1:3000) and developed with 0.3 mg/ml
p-nitro blue tetrazolium chloride plus 0.15 mg/ml 5-bromo-4-
chloro-3-indolyl phosphate-toluidine salt. Alternatively, blots
were incubated with '251-iodinated goat anti-rabbit polyclonal
serum (1:3000) for one hour following incubation with rabbit
anti-M-CSF. Blots were extensively washed and autoradiogra-
phy with an intensifying screen was carried out at —70°C.
Statistical analysis
Statistical analysis was performed with the Statview SE+
package (Abacus Concepts, Berkeley, California, USA). Treat-
ment groups were compared by one way analysis of variance.
All results are expressed as mean SD.
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Table 1. Unstimulated MRL-lpr mesangial cells secrete less M-CSF
Hours
CFU
C3H MRL-lpr
48
72
96
36 5 (l3.8)a
109 7(3.1)
108 6 (8.6)
14 1(6.7)
26 11(0.2)
16 6 (0.9)
Mesangial cells were plated at I x io cells/well and supernatants
assayed for M-CSF at three time points from three separate experi-
ments. M-CSF was measured as colony forming units (CFU) per l0
bone marrow cells in semisolid agar. Results are expressed as mean
SD. The standard in this assay was sera from a C3H/HeN mouse
injected with LPS six hours before sera collection (121 CFU/105 bone
marrow cells) and mouse rGM-CSF (5 ng/ml) (65 CFU/l05 bone marrow
cells).
aTo normalize these values for differential cell counts, results are
expressed as CFU/MC x l0 viable cells. Viability was assessed by
Trypan blue exclusion.
Results
Unstimulated MRL-lpr MC mice secret e less M-CSF than
C3H MC, but TNFcs increases secretion by MRL-lpr MC and
not by C3H MC
For these experiments, confluent monolayers of MC were
trypsinized and 1 x io cells in 2 ml of media were added to
each well of a six well tissue culture plate (Falcon, Cambridge,
Massachusetts, USA). At 48, 72 and 96 hours after plating,
supernatants were obtained from the confluent monolayers and
the cells were trypsinized and counted. Viable cells were
determined by trypan blue exclusion. Secreted M-CSF activity
was determined from the supernatants in a separate CSA assay,
and surface expression was analyzed using flow cytometry.
At all time points, secreted M-CSF was lower in MRL-/pr
MC than C3H MC (Table 1). This difference remained whether
the M-CSF was assessed as the total M-CSF or whether the
M-CSF was normalized for the number of viable cells at the
time the supernatant was obtained.
We also stimulated the cultured MC for 24 hours with TNFa
at various concentrations and compared secreted M-CSF in
C3H and MRL-/pr stimulated and unstimulated MC. TNFa
increased M-CSF secretion in the MRL-lpr MC, but not the
C3H MC (Fig. 1). In the MRL-lpr, TNFa 10 ng/ml stimulation
increased M-CSF secretion by twofold above unstimulated cells
(68 3 vs. 30 7), but did not increase M-CSF secretion in
C3H MC (59 2 vs. 54 4) (Fig. 1). The maximal amount of
M-CSF secreted was also modestly greater in stimulated MRL-
lpr MC compared to C3H MC (68 3 CFU vs. 59 2 CFU).
This result was confirmed in a second experiment (41 4 CFU
for C3H MC vs. 31 0 CFU for MRL-lpr MC, P  0.05).
Autoimmune MRL-lpr express less surface M-CSF than
normal C3H mice
Surface expression is not regulated by TNFa. Indirect flow
cytometric analysis of trypsinized cells was used to assess
surface expression of M-CSF. Surface expression was less in
the MRL-/pr MC than the C3H MC and constant between 48 to
96 hours. The percentage of MRL-lpr MC positive for surface
M-CSF (24 5%) was one-third that of the C3H MC (78 5%);
(Table 2). To determine whether the differences among the cell
lines were unique to our specific cell lines, we cultured out fresh
Strain C3H MRL-Ipr
Fig. L TNFa increases secreted M-CSF in MRL-lpr MC. Mesangial
cells from C3H or MRL-lpr mice were stimulated with various concen-
trations of TNFa for 24 hours: (El) media; () TNF 0.01 ng; (E) TNF
1.0 ng; (•) 10 ng. Supernatants were harvested, stored at —20°C and
then assayed in duplicate for the presence of M-CSF. This value
represents means SD of duplicate experiments. This data represent 1
of 2 similar experiments.
Table 2. Cell surface M-CSF is expressed by fewer MRL-lpr MC
Strain Positive %
C3H
MRL-lpr
L929
CH33
78±5
24 5
98±12±0
MC lines from a second C3H/FeJ mouse and a congenic
MRL-+ + mouse, which were 2 to 4 months of age. It should be
noted that MRL-+ + are normal and do not develop renal injury
during the first year of life [16]. The secondary cell lines were
passaged at least five times to eliminate other contaminating cell
types and to increase the homogeneity of the cell lines. In this
experiment, 32% of the original MRL-lpr MC and 14% of the
secondary MRL-lpr cell line were positive for surface M-CSF
(Fig. 2). These amounts were less than the original C3H,
secondary C3H, and the MRL-+ + MC lines, in which 67, 70,
and 59% of cells were positive for surface M-CSF. In addition,
the mean log fluorescence intensity was much less in the
MRL-/pr MC indicating that not only is the percentage of cells
positive for M-CSF less, but the density of surface M-CSF is
much less, as well.
We next determined the role of TNFa in the regulation of
surface expression of M-CSF. By flow cytometric analysis,
there was not a concomitant increase in membrane M-CSF with
TNFa stimulation in either the MRL-lpr or the C3H MC (Table
3). These observations are in contrast with the ability of TNFa
to induce M-CSF secretion and suggest that TNFa may alter
release of intracellular stores or induce more rapid turnover of
surface M-CSF in the stimulated MRL-/pr MC as compared to
normal MC.
C')
C)C
E
04-
C0
00
Confluent monolayers were trypsinized, plated at 1 x l0 cells/well,
grown for 48 to 96 hours then trypsinized again, stained for surface
M-CSF and assayed by flow cytometry. Results are mean SD of three
experiments. P < 0.01 C3H versus all groups and MRL-lpr versus all
groups.
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Fig. 2. Mesangial cells from MRL.lpr mice
express less surface M-CSF. Mesangial cells
were cultured from C3H and MRL-lpr mice,
trypsinized and stained for the presence of
M-CSF. A secondary cell line was established
from different mice and stained similarly.
L929 cells were used as a positive control and
CH33 as a negative cell line. The column
under control is background fluorescence and
the % of cells positive is shown in the upper
o right hand corner. One of at least two similar
experiments is shown. Background
o fluorescence intensity is marked by the cursor
and differs between different cell types, but
was not altered by the antibody within each
individual cell type.
Table 3. TNF does not induce surface M-CSF expression on
mesangial cells
Treatment
Experiment 1 Positiye % Experiment 2
Strain
C3H
Strain
MRL.lprC3H MRL-lpr
Media
TNF ng/ml
0.01
1.00
10.00
83
75
94
87
28
24
18
19
67
61
57
56
32
23
30
30
Confluent monolayers were trypsinized, plated at 1 x io cells/well,
grown for 24 hours then trypsinized again, stained for surface M-CSF
and assayed by flow cytometry.
MC secrete M-CSF and not GM-CSF. M-CSF was originally
purified from mouse fibroblast L cells [17]. M-CSF eDNA was
cloned from and shown to be expressed by an L cell derivative,
mouse fibroblast L929 cells [18]. Thus, these cells were used as
a positive control. To determine specificity of CFU, MC
supernatants or L929 supernatants were incubated with dilu-
tions of anti-M-CSF or anti-GM-CSF. Colony formation was
inhibited by dilutions of anti-M-CSF (>1:1000), but not by
anti-GM-CSF (1:20). Similar results were obtained using a
proliferation assay (Table 4). Proliferation of normal bone
marrow induced by C3H MC or MRL-lpr MC supernatant was
completely blocked by anti-M-CSF, but not anti-GM-CSF. To
ensure specificity, anti-M-CSF (1:100) was neutralized by incu-
bating with L929 SN from confluent L929 cells after six days of
growth. Cells were then stained with anti-M-CSF or with the
neutralized antibody at the same dilution of anti-M-CSF. A 1:1
mixture of L929 SN: anti-M-CSF (1:100) blocked detection in
the C3H MC (68% to 9%) and MRL-lpr MC (28% to 14%).
MC express a 31 kDa form of M-CSF. Immunoprecipitated
cell lysates from L929 cells (lane 2), C3H, MRL-lpr MC (lanes
3, 4) but not CH33 tumor cells (lane I) expressed a prominent 31
Table 4. Neutralization of mesangial cell supernate CSF activity with
anti-M-CSF
CSF Activity ()HCpM)a
N.R. Anti-M- N.G. Anti-GM-
Media serumb CSFC serum" CSFe
C3H 27,116 21,863 193 30,173 25,427
MRL-lpr5 7,176 6,957 125 5,791 5,516
L-Cell" 7,226 7,519 103 6,890 7,368
mrGM-CSF' 44,631 54,762 49,850 47,433 183
a CSF Activity measured by the proliferation (3H-CPM incorpora-
tion) of normal murine bone marrow cells after three days culture in the
presence of 50 d of test sample, 50 1.il of anti-serum or media plus
100,000 normal bone marrow cells
b N,R. serum, normal rabbit serum (final dilution of 1:320)
'Anti-M-CSF, rabbit anti-murine M-CSF serum (final dilution of
1:320)
d N.G. serum, normal goat serum (final dilution of 1:320)
Anti-GM-CSF, goat anti-murine GM-CSF serum (final dilution of
1:320)
C3H cell supernatant, cells grown to confluence for seven days and
supernatants collected
MRL-lpr cell supernatant, cells grown to confluence for seven days
and supernatants collected
ii L-cell supernatant, L929 cell culture supernatants (24 hr)
mouse rGM-CSF, 5 ng/ml
kDa band (Fig. 3). In addition to the L929 cell lysate as a
positive control, L929 supernatant was also electrophoresed
and blotted (lane 7). Faint bands are visible at 31 kDa. Addi-
tionally, non-specific bands at 49 and 58 kDa are seen in all the
lanes of the immunoprecipitated cell lysates demonstrating that
protein was loaded in all these lanes and available for specific
binding to the anti-M-CSF. In a separate experiment (not
shown) using '251-goat anti-rabbit antibody and autoradiogra-
phy of immunoprecipitated and non-immunoprecipitated cell
extracts, a 16 kDa species was also evident in the extracts from
L929 cells, C3H MC and MRL-lpr MC, but not from the CH33
B cell line.
a,
E
a)
C.)
a,
>
CD
a)
C3H-1 0
MRL-/pr-1
Control M-CSF
-.
63
•0 A. 32
70
4L 14
59
6&.
- 98
iI&L
6
C3H-2
U)
CD
MRL-/pr-2
MRL-+ +
L929
CH33
Log fluorescence intensity
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Fig. 3. Mesangial cells express a 31 kDa form of M-CSF. Cell lysates
from C3H, MRL-/pr, MC, L929 and CH33 cells, and L929 supernatant
were analyzed by Western Blot. Non-specific bands of approximately
49 and 58 kDa are evident in all cell lysate lanes (lanes 1—4), indicating
similar levels of protein were loaded. Specific bands are present at 31
kDa in the MC and L929 cell lysates as well as the L929 SN. These are
not present in the CH33, the negative cell type.
Discussion
Systemic lupus erythematosus is a devastating illness asso-
ciated with a mesangioproliferative glomerulonephritis. MRL-
lpr mice, a murine model of SLE, develop mesangioprolifera-
tive glomerulonephritis with macrophage infiltration into the
glomerulus and an increased expression of TNFa and IL-1/3
transcripts [1, 21. The MRL-/pr strain has extemely high levels
of circulating M-CSF at one week, long before disease is
present [5]. At older ages the source of the increased M-CSF is
in part attibutable to the kidney. Because MC are known to
make M-CSF [6, 71 and because MC proliferate in glomerulo-
nephritis, we investigated whether any intrinsic differences
existed between cultured MC from normal and MRL-lpr mice,
specifically whether MRL-/pr MC could account for the in-
crease in renal M-CSF. Unexpectedly, cultured MC from
MRL-/pr mice secreted and expressed less M-CSF basally than
MC from C3H mice. TNFa stimulation doubled M-CSF secre-
tion by MRL-/pr MC and did not increase secretion of M-CSF
by C3H MC. Total levels from the cultured MRL-lpr MC
stimulated with TNFs, however, were only modestly higher
than those from the C3H MC. Membrane M-CSF was not
increased with TNFa stimulation in either of the cell lines.
However, since there are more MC in MRL-lpr with nephritis
than in normal mice, an increase in MC number may be
responsible for the enhanced generation of M-CSF.
This study highlights the novel observation of surface M-CSF
expression on non-transfected cells. Although others have
demonstrated cell surface M-CSF on transfected COS cells
[19], our studies are the first to report cell surface M-CSF on
MC. In addition, these studies point out a difference between
surface M-CSF on MC from normal mice and from mice with
autoimmune disease. It is unlikely that this cell membrane
M-CSF is anything other than surface bound M-CSF for several
reasons. The positive control L929 cells, from which M-CSF
was first purified, expressed elevated levels of M-CSF that were
similar to the C3H MC and more than the MRL-lpr MC by flow
cytometry. A negative cell type, the CH33, had virtually no
detectable M-CSF. It is also unlikely that we detected M-CSF
that had been secreted and then bound to the M-CSF receptor.
The 16 and 31 kDa forms of M-CSF we detected on Western
blot are consistent with previous reports in other cell types [17,
20], and inconsistent with simultaneous detection of M-CSF
bound to the M-CSF receptor. Further evidence against this
possibility is as follows: (1) L929 cells tack c-fms, the M-CSF
receptor [21]; (2) the same size moiety (31 kDa) on Western
blots of cell lysates were seen in the L929 cells and the MC; (3)
the fluorescence patterns by flow cytometry were seen in the
L929 cells and MC. Although MC have been reported to
express c-fms and to bind M-CSF [71, since the number of
copies of the receptor expressed is extremely small, it is
unlikely c-fms expression could account for the density of
M-CSF observed as reflected by the intensity of staining and
mean log fluorescence. Finally, we were unable to detect c-fms
in our cells by Northern blot analysis (not shown). However, it
is possible that the RNA probed had below detectable levels
since we did not prepare poly (dt) purified RNA as previously
reported [7].
Although expression of M-CSF by MC and in the circulation
of autoimmune mice could be an epiphenomena, we favor the
suggestion that M-CSF is central to the pathogenesis of lupus
nephritis in MRL-lpr mice. M-CSF is a macrophage chemoat-
tractant [1] as well as a growth and differentiation factor
[reviewed in 2]. MRL-/pr MC reside in a milieu in which there
is increased TNFa [3, 4]. TNFa is known to stimulate M-CSF
in other cell types [22, 23], and we have shown that TNFa
increased secretion of M-CSF in MRL-lpr MC. Increased renal
M-CSF and possibly circulating M-CSF may be secondary to
the increased renal TNFa. Therefore, cytokine stimulation may
enhance the production of M-CSF by MC and in turn recruit
macrophages to the glomerulus. Alternatively, macrophages
may be attracted to the mesangium by other stimuli and then
stimulate MC to generate M-CSF. This mechanism may not be
operative in all forms of renal injury. Another autoimmune
strain, the NZB/W Fl female hybrid does not have elevated
levels of circulating M-CSF at any age [5]. Of note, the MC
from these NZB/W mice have a secreted and surface expression
of M-CSF similar to the normal C3H strain (unpublished data).
This is not surprising since the expression of lupus is very
distinctive in these models and there are few established
common denominators.
A less obvious and more intriguing feature of M-CSF in
MRL-lpr mice lies in the fact that M-CSF and stem cell factor
(SCF) share genetic and structural homology [24], suggesting a
0 -J
z
Cl)
C,,0 -J
-— 31 kDa
284 Brennan et a!: Mesangia! cell surface and secreted M-CSF
more fundamental role for M-CSF in cell growth and regulation.
As further support of this expanded role, M-CSF has been
found to act as a "start factor" to stimulate cyclins and move
cells from the G1 to S phase of the cell cycle [25]. Thus, M-CSF
may play a role locally in the proliferation of macrophages and
other cell types. In fact, recent experiments in our own labora-
tory indicate that M-CSF is responsible for stimulating glomer-
ular macrophages to divide as well as maintaining their viabil-
ity. Further studies exploring this action of M-CSF within the
kidney are in progress.
Finally, we appreciate that these studies, which are restricted
to the examination of cultured mesangial cells, may not reflect
the expression of MC M-CSF in vivo. In fact, since there is
enhanced cytokine levels, immunoglobulins, and a myriad of
other molecules in the renal cortex and circulation of MRL-lpr
mice as compared to normal mice, the enviroi tnent will cer-
tainly influence M-CSF expression. We are curn ntly extending
our studies and examining MC in renal tissues of MRL-lpr mice
for both mRNA transcripts and the production of M-CSF.
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